U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07597421) titled 'Fecal Microbiota Transplantation in Parkinson's Disease.' on May 13.
Brief Summary: Fecal microbiota transplantation (FMT) is an effective and safe treatment for Clostridioides difficile infection (CDI). Though CDI is the only indication for FMT, more and more preliminary data on FMT in neurological disorders are reported due to gut-brain axis. This study is a pilot study to apply FMT on patients with Parkinson's disease (PD). The effect of FMT on motor and non-motor symptoms in PD will be also evaluated.
Study Start Date: Sept. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Parkinson's Disease
Intervention:
PROCEDURE: Fecal mi...